NRG1/ErbB4 signaling is strongly linked to working memory dysfunction, and several recent studies have investigated its relevance as a candidate therapeutic pathway for schizophrenia (Yamazaki and Sumikawa 2017; Chung et al. 2018; Hasan et al. 2020). The gene discussed is NRG1; the disease is schizophrenia.